Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Aug;94(4):1149–1156. doi: 10.1111/j.1476-5381.1988.tb11633.x

The actions of neuropeptide Y and peptide YY on the hepatic arterial and portal vascular beds of the anaesthetized dog.

R Corder 1, P G Withrington 1
PMCID: PMC1854102  PMID: 3207978

Abstract

1. The vascular actions of the two peptides, neuropeptide Y (NPY) and peptide YY (PYY) were compared with the transmitter noradrenaline (NA) on the arterial and portal vascular beds of the in situ liver of the anaesthetized dog. 2. The sole vascular response of the hepatic arterial vasculature to intra-arterial administration of either NPY or PYY was vasoconstriction; the duration of these responses was longer than that to NA. 3. The maximum hepatic arterial vasoconstrictor responses to PYY and to NPY were significantly different and they were both significantly less than the maximum to NA (P less than 0.001). 4. In contrast to its activity on the splenic arterial vasculature PYY was not more potent, on a molar basis, than NPY as an hepatic arterial vasoconstrictor agent. However, both peptides were significantly more potent than NA (P less than 0.005). 5. Neither peptide, when injected intraportally, caused any change in intrahepatic portal inflow resistance. 6. Both peptides when administered intraportally in doses which were free of systemic effects caused hepatic arterial vasoconstriction.

Full text

PDF
1150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Bacarese-Hamilton A. J., Smith H. A., Chohan P., Manolas K. J., Bloom S. R. Distribution and postprandial release of porcine peptide YY. J Endocrinol. 1987 Apr;113(1):11–14. doi: 10.1677/joe.0.1130011. [DOI] [PubMed] [Google Scholar]
  2. Allen J. M., Gu J., Adrian T. E., Polak J. M., Bloom S. R. Neuropeptide Y in the guinea-pig biliary tract. Experientia. 1984 Jul 15;40(7):765–767. doi: 10.1007/BF01949769. [DOI] [PubMed] [Google Scholar]
  3. Bond J. H., Prentiss R. A., Levitt M. D. The effects of feeding on blood flow to the stomach, small bowel, and colon of the conscious dog. J Lab Clin Med. 1979 Apr;93(4):594–599. [PubMed] [Google Scholar]
  4. Carneiro J. J., Donald D. E. Change in liver blood flow and blood content in dogs during direct and reflex alteration of hepatic sympathetic nerve activity. Circ Res. 1977 Feb;40(2):150–158. doi: 10.1161/01.res.40.2.150. [DOI] [PubMed] [Google Scholar]
  5. Corder R., Lowry P. J., Wilkinson S. J., Ramage A. G. Comparison of the haemodynamic actions of neuropeptide Y, angiotensin II and noradrenaline in anaesthetised cats. Eur J Pharmacol. 1986 Feb 11;121(1):25–30. doi: 10.1016/0014-2999(86)90388-2. [DOI] [PubMed] [Google Scholar]
  6. Corder R., Lowry P. J., Withrington P. G. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog. Br J Pharmacol. 1987 Apr;90(4):785–790. doi: 10.1111/j.1476-5381.1987.tb11232.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edvinsson L. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries. Acta Physiol Scand. 1985 Sep;125(1):33–41. doi: 10.1111/j.1748-1716.1985.tb07690.x. [DOI] [PubMed] [Google Scholar]
  8. Edvinsson L., Ekblad E., Håkanson R., Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol. 1984 Oct;83(2):519–525. doi: 10.1111/j.1476-5381.1984.tb16516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ekblad E., Winther C., Ekman R., Håkanson R., Sundler F. Projections of peptide-containing neurons in rat small intestine. Neuroscience. 1987 Jan;20(1):169–188. doi: 10.1016/0306-4522(87)90010-8. [DOI] [PubMed] [Google Scholar]
  10. Gallavan R. H., Jr, Chou C. C., Kvietys P. R., Sit S. P. Regional blood flow during digestion in the conscious dog. Am J Physiol. 1980 Feb;238(2):H220–H225. doi: 10.1152/ajpheart.1980.238.2.H220. [DOI] [PubMed] [Google Scholar]
  11. Hopkinson B. R., Schenk W. G., Jr The electromagnetic measurement of liver blood flow and cardiac output in conscious dogs during feeding and exercise. Surgery. 1968 Jun;63(6):970–975. [PubMed] [Google Scholar]
  12. Lundberg J. M., Rudehill A., Sollevi A., Theodorsson-Norheim E., Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett. 1986 Jan 2;63(1):96–100. doi: 10.1016/0304-3940(86)90020-0. [DOI] [PubMed] [Google Scholar]
  13. Lundberg J. M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand. 1982 Dec;116(4):393–402. doi: 10.1111/j.1748-1716.1982.tb07157.x. [DOI] [PubMed] [Google Scholar]
  14. Lundberg J. M., Tatemoto K., Terenius L., Hellström P. M., Mutt V., Hökfelt T., Hamberger B. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4471–4475. doi: 10.1073/pnas.79.14.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lundberg J. M., Terenius L., Hökfelt T., Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett. 1983 Dec 2;42(2):167–172. doi: 10.1016/0304-3940(83)90401-9. [DOI] [PubMed] [Google Scholar]
  16. Pappas T. N., Debas H. T., Chang A. M., Taylor I. L. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology. 1986 Dec;91(6):1386–1389. doi: 10.1016/0016-5085(86)90191-5. [DOI] [PubMed] [Google Scholar]
  17. Richardson P. D., Withrington P. G. Alpha and beta adrenoceptors in the hepatic portal venous vascular bed of the dog [proceedings]. Br J Pharmacol. 1978 Mar;62(3):376P–377P. [PMC free article] [PubMed] [Google Scholar]
  18. Richardson P. D., Withrington P. G. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog. J Physiol. 1978 Sep;282:451–470. doi: 10.1113/jphysiol.1978.sp012475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Richardson P. D., Withrington P. G. The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline. Br J Pharmacol. 1977 Jun;60(2):239–249. [PMC free article] [PubMed] [Google Scholar]
  20. Sundler F., Håkanson R., Ekblad E., Uddman R., Wahlestedt C. Neuropeptide Y in the peripheral adrenergic and enteric nervous systems. Int Rev Cytol. 1986;102:243–269. doi: 10.1016/s0074-7696(08)61277-2. [DOI] [PubMed] [Google Scholar]
  21. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2514–2518. doi: 10.1073/pnas.79.8.2514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5485–5489. doi: 10.1073/pnas.79.18.5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wahlestedt C., Yanaihara N., Håkanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept. 1986 Feb;13(3-4):307–318. doi: 10.1016/0167-0115(86)90048-0. [DOI] [PubMed] [Google Scholar]
  24. de Quidt M. E., Emson P. C. Neuropeptide Y in the adrenal gland: characterization, distribution and drug effects. Neuroscience. 1986 Nov;19(3):1011–1022. doi: 10.1016/0306-4522(86)90313-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES